Derek

Primary hypogonadism in males typically presents with elevated gonadotropins due to insufficient negative feedback on the pituitary and hypothalamus.

"So if you're primary hypogonadal, you would see the reflection typically of high gonadotropins" (said at 0:25:43)

No published record matching the claim that primary hypogonadism in males typically presents with elevated gonadotropins due to insufficient negative feedback on the pituitary and hypothalamus was located; this does not prove the claim false.

Ketogenic and zero-carbohydrate diets significantly elevate SHBG and lower free testosterone because insulin signaling is required to suppress SHBG.

"If you're on a ketogenic diet, you can absolutely expect your SHBG levels to be through the roof and your free test to be much lower. So carnivore diet guys, there's a reason they eat fruit now. It's because their free test levels are all shit and their total test levels were high and they thought it was fine. But in reality, they had like borderline hypogonadal free test levels often because they were overlooking the fact that insulinergic signaling is needed to actually get SHBG to a meaningfully reasonable level for a male." (said at 0:33:10)

No published record matching the claim that ketogenic and zero-carbohydrate diets cause borderline hypogonadal free testosterone levels through lack of insulin-mediated SHBG suppression was located; this does not prove the claim false.

KSM-66 ashwagandha is standardized to 5% withanolides, whereas Sensoril is standardized to 10% withanolides.

"And depending on if you have KSM-66, that's 5%; Sensoril is 10%." (said at 1:11:08)

No published record matching the specific standardization percentages of KSM-66 (5% withanolides) and Sensoril (10% withanolides) was located in the fetched abstracts; this does not prove the claim false.

Dr. Peter Attia successfully treated his secondary hypogonadal testosterone deficiency by using hCG as an LH mimetic to stimulate endogenous testicular hormone production.

"Like Peter, for example, like he's pretty dialed and he did a lot of stuff to try and like fix it before he went to any sort of replacement. Sleep hygiene is on point. Like the guy—what else could you do when you're him, right? He's I think 50 years old. So what he did was he used hCG, which was assessing, okay, are the testes responding to like a manual signal? And they were, and he's like replaced his hormones entirely by using a manual LH mimic essentially." (said at 1:28:20)

No published record matching the claim that Dr. Peter Attia successfully treated secondary hypogonadal testosterone deficiency using human chorionic gonadotropin (hCG) monotherapy was located; this does not prove the claim false. While hCG is clinically recognized as a luteinizing hormone analog capable of stimulating testicular testosterone production in men with secondary hypogonadism, this specific individual clinical case has not been documented in the published medical literature.

Testosterone therapy can exacerbate obstructive sleep apnea.

"sleep apnea will get exacerbated pending your neck size increases, muscle increases in size, things that are contributing to the obstructive nature of your soft tissue falling into your airway will get worse pending you are dosing in a manner that pushes you there." (said at 1:48:55)

No published record matching the claim that testosterone therapy exacerbates obstructive sleep apnea by increasing neck size and airway soft tissue was located; this does not prove the claim false.

Testosterone cypionate has an elimination half-life of approximately 8 to 10 days.

"So cypionate has a half-life of like I think it's like 10 days or something, 8 to 10 days, depending on individual biochemistry and how you kind of like cleave the ester." (said at 1:58:20)

No published record matching the claim that testosterone cypionate has an elimination half-life of 8 to 10 days was located; this does not prove the claim false.

Australia has approved testosterone formulations specifically for use in women.

"there's no FDA-approved medication for women for testosterone in the US. There is in Australia apparently, which is kind of wild considering it's like the most regulated place ever that is like almost nothing's legal there, but somehow like testosterone is for women shockingly." (said at 2:28:10)

No published record matching the claim that Australia has approved testosterone formulations specifically for use in women was located; this does not prove the claim false.

Cosmetic differences in hair density are typically not visibly noticeable until at least 25% of hair has been lost.

"And you won't even notice the cosmetic difference in hair density until you've lost like 25-plus percent of your hair." (said at 2:46:05)

No published record matching the claim that cosmetic differences in hair density are typically not visibly noticeable until at least 25% of hair has been lost was located; this does not prove the claim false.

Minoxidil was originally developed and approved as an oral blood pressure medication under the brand name Loniten and carries a black box warning.

"So it's like a very terrible blood pressure drug. So it was originally prescribed for high blood pressure as Loniten oral... because it's essentially a really bad blood pressure drug with a black box warning on it." (said at 2:56:31)

No published record matching the claim that minoxidil was originally approved as an oral blood pressure medication under the brand name Loniten and carries a black box warning was located; this does not prove the claim false.

Dihydrotestosterone (DHT) is entirely inactivated in muscle tissue, providing no muscle growth benefit in adults.

"DHT is entirely inactivated in muscle tissue, so you get no muscle growth benefit." (said at 3:08:11)

No published record matching the claim that dihydrotestosterone is entirely inactivated in muscle tissue and provides no muscle growth benefit was located; this does not prove the claim false.

Inhibiting the 5-alpha reductase enzyme results in a proportional increase of 15% to 20% in intra-tissue estradiol.

"I have a net increase in intra-tissue aromatization from the inhibition of the 5-AR enzyme. So in all the tissues that would otherwise be pro-longevity from estrogen locally, you're getting a benefit. You're getting the proportional increase of 15 to 20% of intra-tissue estradiol." (said at 3:09:14)

No published record demonstrating a consistent 15% to 20% proportional increase in intra-tissue estradiol from 5-alpha reductase (5-AR) inhibition was located; this does not prove the claim false. While inhibiting 5-AR reduces the conversion of testosterone to dihydrotestosterone (DHT) and can theoretically shift available substrate toward aromatization, clinical trials and meta-analyses assessing 5-AR inhibitors (such as finasteride and dutasteride) have reported inconsistent or non-significant changes in estradiol levels, without robust evidence establishing a uniform 15% to 20% increase in tissue-level estradiol.

• contradicts: Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Re… (Sexual medicine reviews 2019) · cited 10x in the literature

  "10 studies reported luteinizing hormone, follicle-stimulating hormone, SHBG, and estradiol values and none reported significant changes in their levels, suggesting that observed changes in serum T levels are unlikely mediated by gonadotropins levels or peripheral conversion of T to estradiol." (abstract, results, passage verified)

  pubmedfull study (doi)
• context: Impact of 5-alpha reductase inhibitors on male reproductive health: A review of finasterid… (Reproductive toxicology (Elmsford, N.Y.) 2026)

  "Hormonal alterations included, increased testosterone levels, and variable changes in dihydrotestosterone, estradiol, progesterone and androstenedione levels." (abstract, results, passage verified)

  pubmedfull study (doi)